MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    The East London Parkinson Disease Project: Higher Immune Activation found in Patients with Parkinson’s Disease Dementia from a Diverse Population

    A. Zirra, KC. Dey, E. Camboe, E. Bhadra, B. Huxford, R. Laban, N. Donkor, F. Nice, S. Valle Thomas, A. Gaspariunas, L. Mitchell, DA. Gallagher, C. Budu, C. Simonet, T. Boyle, AJ. Lees, D. Yadin, J. Dias, O. Cavlan, CR. Marshall, MT. Perinan, AJ. Noyce (London, United Kingdom)

    Objective: The scope of this work was to characterise the B-cell receptor repertoire of patients with Parkinson’s disease with dementia (PDD), cognitively resilient (PDR) and…
  • 2025 International Congress

    Prodromal Lewy body dementia features in isolated REM sleep behavior disorder with neuronal synuclein disease

    D. Weintraub (Philadelphia, USA)

    Objective: To assess for cognitive impairment and features of prodromal Lewy body dementia (LBD) in persons with isolated REM sleep behavior disorder (iRBD) and neuronal…
  • 2025 International Congress

    Evaluation Of Visual Perception Using Noise Pareidolia Test in Bangladeshi Patients with Parkinson’s disease.

    T. Zannat, E. Camboe, K. Dey, A. Zirra, A. Haque, D. Mair, S. Waters, C. Marshall, N. Mukadam, R. Weil, A. Noyce, A. Habib (Dhaka, Bangladesh)

    Objective: To evaluate the prevalence of visual misperception in patients with PD (PwP) in comparison with healthy control (HC) and its association with visual hallucinations.…
  • 2025 International Congress

    The role of interoception in motor imagery in Parkinson’s disease

    J. Bek, M. Lavasidis, N. Brady, T. Welsh (Dublin, Ireland)

    Objective: The present study explored the relationship between interoceptive awareness and motor imagery in individuals with PD. Background: Motor imagery is the imagination of movement,…
  • 2025 International Congress

    The Role of Depression and Anxiety in the Progression of Parkinson’s Disease

    N. Dahodwala, C. Hurley, T. Kapogiannis, H. Cho, C. Caspell-Garcia, D. Weintraub, R. Dobkin (Philadelphia, USA)

    Objective: To determine the association of depression and anxiety, and their treatment, with patient-reported outcomes (PROs) in a large, online, observational cohort of people with…
  • 2025 International Congress

    Approach into the genetics of cognitive performance in Mexican Parkinson’s Disease patients.

    A. Lázaro Figueroa, P. Reyes-Pérez, A. Morales, E. Morelos-Figaredo, C. Guerra-Galicia, I. Estrada-Bellmann, N. Gandarilla-Martínez, K. Salinas-Barboza, D. Oropeza, J. Esquivias, I. Hernández-Ruiz, G. de Anda, E. Waldo, T. Leal, M. Inca-Martinez, I. Mata, S. Alcauter, M. Rentería, A. Medina-Rivera, A. Ruiz-Contreras (CDMX, Mexico)

    Objective: To compare the allele frequencies of genetic variants associated with cognitive impairment between Parkinson's Disease (PD) patients and controls and to examine their interaction…
  • 2025 International Congress

    CSF Biomarker-based Cognitive Trajectories in Parkinson’s Disease-Subjective Cognitive Decline

    J. Rodriguez-Antiguedad, A. Puig-Davi, I. Ruiz-Barrio, J. Pagonabarraga, A. Vazquez-Oliver, A. Horta-Barba, S. Martinez-Horta, J. Kulisevsky (Barcelona, Spain)

    Objective: To investigate associations between CSF biomarkers and cognitive decline in Parkinson’s Disease-Subjective Cognitive Decline (PD-SCD). Background: The presence of cognitive complaints without objective cognitive…
  • 2025 International Congress

    Distinguishing Functional and Essential Tremor from Tremor in Parkinson’s Disease using an objective comprehensive Motor Symptom Assessment Device

    D. Bramwell, C. Papasavvas, M. Walter, A. Dimelow, A. Deutschländer, R. Zietsma (Newcastle upon Tyne, United Kingdom)

    Objective: Our main aims were to 1) increase diagnostic accuracy and 2) reduce the time needed to reach the correct diagnosis in three disorders with…
  • 2025 International Congress

    1-Year Outcomes for MDS-UPDRS Part I-IV and Clinical Impressions: Insights from a Large Real-World Prospective Study on de novo STN-DBS in Parkinson’s Disease

    S. Groppa, L. Lopez-Manzanares, A. Schnitzler, S. Chen, C. Salazar, Y. Ram, M. Chung, A. Gharabaghi (Homburg, Germany)

    Objective: We present long-term prospective data from the Abbott DBS Post-Market Study of Outcomes for Indications Over Time (ADROIT, NCT04071847) in 233 patients from 41…
  • 2025 International Congress

    Superior cluneal neuralgia in Parkinson’s disease: frequency and clinical features.

    M. Mihara, Y. Kajiyama, A. Saito, R. Satake, Y. Kutoku (Kurashiki, Japan)

    Objective: We investigated the frequency and clinical characteristics of superior cluneal neuralgia (SCN) in patients with Parkinson's disease (PD). Background: The superior cluneal nerve is…
  • « Previous Page
  • 1
  • …
  • 111
  • 112
  • 113
  • 114
  • 115
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • #25179 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley